CGL
BLUE

Clarius Group LLC’s bluebird bio BLUE Stock Holding History

Clarius Group LLC’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-102
Closed -$208K – 265
2019
Q1 		$208K Buy
+102
New +$180K 0.05% 199
2018
Q3 		– Sell
-102
Closed -$207K – 126
2018
Q2 		$207K Hold
102
– – 0.09% 85
2018
Q1 		$225K Hold
102
– – 0.1% 56
2017
Q4 		$235K Buy
+102
New +$207K 0.1% 56
2017
Q3 		– Sell
-562
Closed -$765K – 73
2017
Q2 		$765K Sell
562
-39
-6% -$47.1K 0.32% 37
2017
Q1 		$707K Sell
601
-7
-1% -$7.14K 0.29% 42
2016
Q4 		$486K Buy
608
+61
+11% +$48.4K 0.21% 50
2016
Q3 		$480K Sell
547
-97
-15% -$70.3K 0.22% 51
2016
Q2 		$361K Sell
644
-102
-14% -$57.8K 0.19% 59
2016
Q1 		$410K Buy
+746
New +$458K 0.23% 52

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Clarius Group LLC's BLUE Position: Q2 2019 in Review

Clarius Group LLC sold out of bluebird bio (BLUE) in Q2 2019, closing a stake of 102 shares — an estimated $208K sold.

Clarius Group LLC first reported a position in BLUE in Q1 2016 and held it in 10 quarters. The position peaked at $765K in Q2 2017. 273 funds tracked by Wall St. Rank hold BLUE as of Q2 2019.

  • Clarius Group LLC reported no remaining bluebird bio position as of Q2 2019 after selling out during the quarter.
  • Clarius Group LLC sold 102 bluebird bio shares in Q2 2019, an estimated $208K.
  • Clarius Group LLC first reported a position in bluebird bio in Q1 2016 and held it in 10 quarters.
  • Clarius Group LLC's bluebird bio position peaked at $765K in Q2 2017.
  • 273 funds tracked by Wall St. Rank held bluebird bio as of Q2 2019.

Based on Clarius Group LLC's 13F filing for Q2 2019, filed 2 Aug 2019.